ARCURA
LIVE

Serial Number

50127071

Owner

Arcura Therapeutics

Attorney

Justin Jingwei Sun

Filing Date

Sep 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ARCURA Trademark

Serial Number: 50127071

ARCURA is a trademark filed by Arcura Therapeutics on September 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Arcura Therapeutics (2 trademarks)

Room 401, Building B11, Yinfeng Biocity, No. 1177 Chunlan Road, Juyehe Subdistrict, High-tech Zone
Jinan, Shandong 250000 , CN

Entity Type: 99

Trademark Details

Filing Date

September 24, 2026

Registration Date

Not Registered

Goods & Services

Anti-infectives for human use; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Diagnostic preparations for medical purposes; Hormonal preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical products for the prevention and treatment of cancer; Biochemical reagents for medical or veterinary purposes; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Medicated ointments for treating dermatological conditions; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Vaccines; Biological preparations for use in cell cultures for medical purposes

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 24, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2026 NWOS
NEW APPLICATION ENTERED
Sep 24, 2026 NWAP